These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16352861)

  • 21. Understanding renal and cardiovascular function through physiological genomics.
    Moreno C; Pollock DM
    Physiol Genomics; 2004 Jan; 16(2):178-9. PubMed ID: 14726600
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitric oxide and cardiovascular and renal effects.
    Raij L
    Osteoarthritis Cartilage; 2008; 16 Suppl 2():S21-6. PubMed ID: 18794014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex and gender differences in cardiovascular, renal and metabolic diseases.
    Reckelhoff JF; Samson WK
    Am J Physiol Regul Integr Comp Physiol; 2015 Nov; 309(9):R1057-9. PubMed ID: 26447212
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin resistance and renal disease.
    Fliser D; Kielstein JT; Menne J
    Contrib Nephrol; 2006; 151():203-211. PubMed ID: 16929143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kidney function in endangiitis obliterans; a contribution to the problem of generalization of endangiitis obliterans and of endanglitis hypertension].
    HOLLE F; CARSTENSEN G
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1957; 285(4):397-419. PubMed ID: 13526317
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiocirculatory function in renal disease. International workshop. Strasbourg, September 19-21, 1983.
    Contrib Nephrol; 1984; 41():1-459. PubMed ID: 6525830
    [No Abstract]   [Full Text] [Related]  

  • 27. Endothelial health and diversity in the kidney.
    Segal MS; Baylis C; Johnson RJ
    J Am Soc Nephrol; 2006 Feb; 17(2):323-4. PubMed ID: 16434502
    [No Abstract]   [Full Text] [Related]  

  • 28. The metabolic syndrome: an overview.
    Reisin E; Alpert MA
    Am J Med Sci; 2005 Dec; 330(6):263. PubMed ID: 16355008
    [No Abstract]   [Full Text] [Related]  

  • 29. Endothelin in health and disease.
    Nakas-Ićindić E; Zaciragić A; Hadzović A; Avdagić N
    Bosn J Basic Med Sci; 2004 Jul; 4(3):31-4. PubMed ID: 15629009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copeptin: a biomarker of cardiovascular and renal function.
    Morgenthaler NG
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S37-44. PubMed ID: 20653710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymptomatic hyperuricemia: perhaps not so benign?
    Neogi T
    J Rheumatol; 2008 May; 35(5):734-7. PubMed ID: 18464314
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cardiorenal interactions: clinical implication and role in pathogenesis of cardiovascular and renal diseases].
    Mukhin NA; Moiseev VS; Kobalava ZhD; Moiseev SV; Fomin VV
    Ter Arkh; 2004; 76(6):39-46. PubMed ID: 15332575
    [No Abstract]   [Full Text] [Related]  

  • 33. Natriuretic peptides.
    Levin ER; Gardner DG; Samson WK
    N Engl J Med; 1998 Jul; 339(5):321-8. PubMed ID: 9682046
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular disease in chronic renal disease.
    Levey AS; Eknoyan G
    Nephrol Dial Transplant; 1999 Apr; 14(4):828-33. PubMed ID: 10328452
    [No Abstract]   [Full Text] [Related]  

  • 35. Special Issue on "Frontier Biomechanical Challenges in Cardiovascular Physiopathology".
    Pasta S; Zingales M
    Med Eng Phys; 2017 Sep; 47():1. PubMed ID: 28800897
    [No Abstract]   [Full Text] [Related]  

  • 36. [The bicycle ergometry test in the functional assessment of the cardiovascular system and kidneys].
    Glezer GA; Moskalenko NP; Glezer MG
    Kardiologiia; 1993; 33(7):39-45. PubMed ID: 8309180
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adrenomedullin].
    Bełtowski J
    Postepy Hig Med Dosw; 1999; 53(1):99-123. PubMed ID: 10352550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Examine my kidneys and my heart': linking renal and cardiovascular disease.
    Tietge UJ
    Curr Opin Lipidol; 2017 Feb; 28(1):83-84. PubMed ID: 28030454
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 40. I've heard that heart disease and kidney disease are related, but how exactly? Is it that kidney problems can cause heart problems in a person with a relatively healthy heart, or is it that heart disease can lead to kidney disease in someone with healthy kidneys?
    Heart Advis; 2011 Jan; 14(1):12. PubMed ID: 22973603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.